Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 1Rectal Neoplasms 1Postoperative Analgesia 1Neoplasms 1Biliary Tract Neoplasms 1

Interventions

Gemcitabine 4Cisplatin 4Capecitabine 4Oxaliplatin 3Leucovorin 2Fluorouracil 2Albumin-Bound Paclitaxel 2titanium silicide 1tegafur-gimeracil-oteracil 1surufatinib 1pembrolizumab 1mitazalimab 1durvalumab 1cediranib 1anlotinib 1Taxes 1S 1 (combination) 1Paclitaxel 1Folfox protocol 1Control Groups 1ARRY-334543 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Biliary Tract Neoplasms × Control Groups × Clear all
NCT05065957 2025-04-30

Study of Combination Therapy of D07001-Softgel Capsules and Xeloda/TS-1 in Subjects With Advanced Biliary Tract Cancer

InnoPharmax Inc.

Phase 2/3 Recruiting
180 enrolled
Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡